
Community
Breaking: Patient Death Reported in Soleno’s Genetic Disorder Program
Soleno Therapeutics has reported the death of a 17-year-old patient taking its experimental treatment Vykat XR for hyperphagia in Prader-Willi syndrome. The company said the

